Last reviewed · How we verify
NCT06944327: PICC managemen
Reduction of Complications Associated With PICC Management
NA trial testing MANAGEMENT CARE in Treatment Outcome in 460 participants. Not yet recruiting.
1 October 2027
Quick facts
| Lead sponsor | Fundacion Miguel Servet |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 460 |
| Start date | 1 October 2025 |
| Primary completion | 1 October 2027 |
| Estimated completion | 31 December 2027 |
Drugs / interventions tested
- MANAGEMENT CARE
- traditional care
Conditions studied
- Treatment Outcome — all drugs for Treatment Outcome →
- Vascular Access — all drugs for Vascular Access →
- Vascular Access Device — all drugs for Vascular Access Device →
- Vascular Access Complication — all drugs for Vascular Access Complication →
Sponsor
Fundacion Miguel Servet
Who can join
18 and older, any sex, with Treatment Outcome or Vascular Access. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study aims to analyze different care routes of the peripheral access central venous catheter to assess which alternative allows a moderate reduction in the level of complications associated with prolonged care frequency, due to the reduction of device manipulation. A high level of patient satisfaction is detected due to the controlled follow-up of the device care, as well as a decrease in the need for transfer to a center for follow-up. Objective: Identify the type of care frequency for PIVCs most beneficial for the reduction of complications associated with extraluminal device care (thrombosis, phlebitis, accidental removal, obstruction).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06944327
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Treatment Outcome
Currently open trials in the same condition.
- NCT07018167 — Impact of Door-to-Needle Time on Stroke Outcomes at Gonesse Hospital · active not recruiting
- NCT07054892 — Assessment of the Quality of Life of Patients Visiting the Emergency Department of the Saint-Brieuc Hospital Following a · recruiting
- NCT07034560 — Effectiveness of Oral Melatonin vs Oral Tranexamic Acid in the Treatment and Recurrence of Melasma · Phase 4 · active not recruiting
- NCT06864221 — Plasma Sphingolipid Metabolites and Radiotherapy Efficacy in Hepatocellular Carcinoma · recruiting
- NCT06966141 — A Real World Study of Sacituzumab Govitecan · recruiting
Other Fundacion Miguel Servet trials
Trials by the same sponsor.
- NCT07182292 — Effect of a Combined Exercise and Anti-Inflammatory Nutritional Intervention in Frail Older Adults · NA · not yet recruiting
- NCT06634147 — Prevention of Functional and Cognitive Impairment Through a Multicomponent Exercise Program in Hospitalized Older Adults · NA · recruiting
- NCT06677359 — Impact of Creatine Monohydrate Micronized Supplementation With or Without Multicomponent Training in Older Adults. · NA · recruiting
- NCT06948240 — AF Coronary Embolism Long Term Outcomes · completed
- NCT06340282 — Immersive Virtual Reality and Physical Exercise on Cognitive and Functional Performance in Hospitalized Older Patients · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06944327 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundacion Miguel Servet
- Last refreshed: 25 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06944327.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing